CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

Clinical trial NCT04457700 · UNKNOWN

Trial details

NCT number: NCT04457700
Sponsor: Peking University
Status: UNKNOWN
Study type: OBSERVATIONAL

Triple-negative Breast Cancer HER2-positive Breast Cancer

Start date: 2020-11-01
Primary completion: 2022-07-30
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.